COMMUNIQUÉS West-GlobeNewswire

Idorsia initiates pivotal Phase 3 study for lucerastat in Fabry disease and enters co-development and commercialization agreement with Nxera
28/10/2026
FAB-KLEAR investigates lucerastat as a potential disease-modifying therapy targeting the kidney manifestations of Fabry disease. Nxera will contribute to development and hold commercialization rights in Japan and [...]
Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma
28/10/2026
The VENTANA BAP1 (SP527) test helps confidently distinguish malignant mesothelioma from lung, breast and stomach cancers, as well as benign tissue growth in the chest or abdomen. Most patients are diagnosed with [...]
15-year-old Designs Low-Cost Device to Monitor Airborne Bacteria in the Environment; Wins $25,000 Top Award at the 2026 Thermo Fisher Scientific Junior Innovators Challenge
28/10/2026
Young innovators awarded more than $100,000 for research on dementia-related proteins, alternatives to agricultural plastics and wildfire prevention Key Takeaways: Thermo Fisher Scientific and Society for Science [...]
Junshi Biosciences Announces Final Analysis Results of the Phase 3 NEOTORCH Study at ESMO Congress 2026
28/10/2026
Perioperative toripalimab plus chemotherapy demonstrated significant and durable improvements in event-free survival and overall survival in patients with resectable stage II-III non-small cell lung cancer. SHANGHAI, [...]
Ossium Health CEO Kevin Caldwell Wins 2026 Biocom Catalyst Award
27/10/2026
SAN FRANCISCO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Kevin Caldwell, Ossium Health CEO, Co-Founder & President, has been named a winner of the 2026 Biocom Catalyst Award. Now in its 11th year, the Catalyst Awards honor [...]
INVO Fertility Announces a 1:4 Reverse Stock Split Effective Pre-Market Opening on October 30, 2026
27/10/2026
SARASOTA, Fla., Oct. 27, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the establishment, acquisition and operation of fertility clinics and related businesses and [...]
UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026
27/10/2026
Conference Call and Webcast Scheduled for Wednesday, November 4th, 2026, at 10:00 AM ET PRINCETON, N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and [...]
Latest Data of Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2026
28/10/2026
BEIJING, Oct. 27, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that latest data of [...]
Newsweek Places KFSH in Top 4% of World's Smart Hospitals for Digital Maturity and AI
28/10/2026
RIYADH, Saudi Arabia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) is one of only 15 hospitals worldwide to receive both the maximum five-ribbon digital maturity rating [...]
Venus Williams Reveals Her Secret for What Women Fear Most
27/10/2026
Tennis Legend’s Breast Cancer Prevention PSA Receives Millions of Views in AMC Theaters WASHINGTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Tennis legend Venus Williams has revealed in a new video message her strategy for one [...]
EB Development : communiqué relatif au dépôt de l'offre modifiée
27/10/2026
COMMUNIQUÉ DU 27 OCTOBRE 2026 RELATIF AU DÉPÔT D’UNE OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS DE LA SOCIÉTÉ EUROBIO SCIENTIFIC Pièce jointe 03. EB Development - Communiqué normé - [...]
Eurobio Scientific: communiqué relatif au dépôt de la note en réponse
27/10/2026
COMMUNIQUÉ DU 27 OCTOBRE 2026 RELATIF AU DÉPÔT DU PROJET DE NOTE D’INFORMATION ÉTABLI PAR LA SOCIÉTÉ EUROBIO SCIENTIFIC EN RÉPONSE AU PROJET D’OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS [...]
What Happens During a Dental Implant Consultation in Tukwila
27/10/2026
Candidacy for implants and All-on-X full-arch treatment is evaluated in a single visit, with 3D imaging and digital impressions done in-house. Implants are placed and restored by the same dentist at South Seattle Smiles [...]
Arcutis Management to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
27/10/2026
WESTLAKE VILLAGE, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Cogent Biosciences to Participate in the Guggenheim Healthcare Innovation Conference
27/10/2026
WALTHAM, Mass. and BOULDER, Colo., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today [...]
Praxis Precision Medicines Announces Third Quarter 2026 Financial Results Date, Investor Day and November Conference Participation
27/10/2026
Company to host an in-person and virtual Investor Day on November 12, 2026 BOSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system ( [...]
Arvinas Announces Return of Early Career Researcher Award to Recognize Innovation in Targeted Protein Degradation
27/10/2026
– $25,000 monetary award to recognize an emerging researcher or research team advancing targeted protein degradation – – Nominations open November 1, 2026, and close December 31, 2026; winner to be recognized in mid- [...]
Ligand to Participate in November Investor Conferences
27/10/2026
JUPITER, Fla., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the following upcoming investor conferences: UBS [...]
Beta Bionics Announces Third Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
27/10/2026
IRVINE, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter [...]

Pages